MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), today announced the upcoming launch of Qurr, its Fortetropin(R)-powered product line formulated to support the vital role of muscle in overall well-being as well as in fitness.
The March 2017 introduction of Qurr's muscle-focused, natural, over-the-counter products will make the Qurr line available through convenient direct online ordering without a prescription. All Qurr products are blended with Fortetropin(R), MYOS' pr
RelSci News & Alerts gets you:
- Competitive business intelligence through daily data updates